Low ovarian reserve, premature ovarian insufficiency (POI) and a thin endometrium are among the most difficult challenges in reproductive medicine. Our gynaecologists offer detailed assessment, explain your options clearly and coordinate your care with registered IVF clinics.
A lower-than-expected number of eggs for age, usually shown by a low AMH level and antral follicle count on ultrasound.
Loss of normal ovarian function before the age of 40. It affects fertility and long-term bone and heart health, so hormone replacement and follow-up are important.
A uterine lining that does not thicken enough for embryo implantation, sometimes linked to Asherman's syndrome (scarring inside the uterus).
A review of your medical and fertility history and previous treatment.
Hormone tests (AMH, FSH, LH, oestradiol, thyroid and others as needed) and pelvic ultrasound.
A written explanation of your results and options.
Hormone replacement and bone-health care for women with POI, where appropriate.
Referral to, and coordination with, a registered ART/IVF clinic for fertility treatment.
Researchers worldwide are studying whether ovarian and endometrial PRP, and bone marrow–derived cell concentrates, can help women with POI, poor ovarian reserve or thin endometrium. Early studies are mixed, and these approaches are not yet established treatments.
In India, stem cell and cell-based approaches for these conditions are permitted only within approved clinical trials. StemGenn does not offer them as routine services.
Our founder, Prabhu Chandra Mishra, PhD, is the author of Stem Cell & Regenerative Medicine in Infertility. Clinicians can learn more through IASRM's education programmes.
There is not yet enough evidence to say they can. These approaches are being studied in research settings. Your doctor will explain the established options, including IVF with your own or donor eggs, and whether any approved clinical trial may be relevant to you.
No. We coordinate with registered ART clinics, which provide IVF under the Assisted Reproductive Technology (Regulation) Act, 2021.
Every situation is different. Book a confidential consultation to understand your results and options.